{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:06:17Z","timestamp":1770977177547,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2023E001TS03"],"award-info":[{"award-number":["CI2023E001TS03"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021A04407"],"award-info":[{"award-number":["CI2021A04407"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002418","name":"China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3504000"],"award-info":[{"award-number":["2023YFC3504000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bioorg.2026.109569","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:45:23Z","timestamp":1769618723000},"page":"109569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rational design of novel procaspase-3 activators for the targeted therapy of triple-negative breast cancer"],"prefix":"10.1016","volume":"171","author":[{"given":"Zhongyuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxiaoning","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109569_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103835","article-title":"Current and future burden of breast cancer in Asia: a GLOBOCAN data analysis for 2022 and 2050","volume":"79","author":"Fu","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.bioorg.2026.109569_bb0010","article-title":"Noncommunicable diseases prevention in low- and middle-income countries: an overview of health in all policies (HiAP)","volume":"58","author":"Ndubuisi","year":"2021","journal-title":"Inquiry"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109569_bb0015","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109569_bb0020","doi-asserted-by":"crossref","first-page":"zrae040","DOI":"10.1093\/bjsopen\/zrae040","article-title":"Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis","volume":"8","author":"Rajan","year":"2024","journal-title":"BJS Open"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109569_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13058-024-01936-0","article-title":"Intraoperative radiotherapy versus whole breast radiotherapy in early-stage breast cancer: a retrospective outcome analysis based on ASTRO guidelines on PBI","volume":"26","author":"Gao","year":"2024","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109569_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/medicina57010062","article-title":"Triple negative breast Cancer: a review of present and future diagnostic modalities","volume":"57","author":"Dass","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109569_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.bioorg.2026.109569_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115545","article-title":"Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies","volume":"212","author":"Karim","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109569_bb0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11033-021-06863-3","article-title":"Resistance to endocrine therapy in HR+and\/or HER2+breast cancer: the most promising predictive biomarkers","volume":"49","author":"Miranda","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109569_bb0050","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1021\/acschembio.9b00338","article-title":"Procaspase-3 overexpression in Cancer: a paradoxical observation with therapeutic potential","volume":"14","author":"Boudreau","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109569_bb0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/1120009X.2023.2278014","article-title":"Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review","volume":"36","author":"Dou","year":"2024","journal-title":"J. Chemother."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109569_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118688","article-title":"Targeting apoptotic caspases in cancer","volume":"1867","author":"Boice","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Res."},{"key":"10.1016\/j.bioorg.2026.109569_bb0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41419-024-06884-3","article-title":"Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109569_bb0070","first-page":"4363","article-title":"Expression of cleaved caspase-3 predicts good chemotherapy response but poor survival for patients with advanced primary triple-negative breast cancer","volume":"11","author":"Liu","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2026.109569_bb0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2022.04.014","article-title":"Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC","volume":"346","author":"Kim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioorg.2026.109569_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fonc.2019.00096","article-title":"Immunohistochemical characterization of Procaspase-3 overexpression as a druggable target with PAC-1, a Procaspase-3 activator, in canine and human brain cancers","volume":"9","author":"Schlein","year":"2019","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109569_bb0085","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/ijms26083466","article-title":"Apoptotic Caspases-3 and -7 cleave extracellular domains of membrane-bound Proteins from MDA-MB-231 breast Cancer cells","volume":"26","author":"Vidak","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109569_bb0090","doi-asserted-by":"crossref","first-page":"dju403","DOI":"10.1093\/jnci\/dju403","article-title":"Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapy","volume":"107","author":"Lee","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109569_bb0095","doi-asserted-by":"crossref","first-page":"1800368","DOI":"10.1002\/advs.201800368","article-title":"Self-triggered apoptosis enzyme prodrug therapy (STAEPT): enhancing targeted therapies via recurrent bystander killing effect by exploiting caspase-cleavable linker","volume":"5","author":"Chung","year":"2018","journal-title":"Adv. Sci."},{"issue":"28","key":"10.1016\/j.bioorg.2026.109569_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2019.01.020","article-title":"The novel strategy for concurrent chemoradiotherapy by conjugating the apoptotic cell-binding moiety to caspase-3 activated doxorubicin prodrug","volume":"296","author":"Cho","year":"2019","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.bioorg.2026.109569_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nchembio814","article-title":"Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy","volume":"2","author":"Putt","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109569_bb0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41416-022-02089-7","article-title":"Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies","volume":"128","author":"Danciu","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109569_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003034","article-title":"Caspase 3 and caspase 7 promote cytoprotective autophagy and the DNA damage response during non-lethal stress conditions in human breast cancer cells","volume":"23","author":"Samarasekera","year":"2025","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109569_bb0120","first-page":"348","article-title":"Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.bioorg.2026.109569_bb0125","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1080\/10408398.2024.2398636","article-title":"Therapeutic potential of dietary bioactive compounds against anti-apoptotic Bcl-2 proteins in breast cancer","volume":"65","author":"Shenoy","year":"2025","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109569_bb0130","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.3390\/ijms26072964","article-title":"Synergistic effects of oxaliplatin, 5-fluorouracil, and novel synthetic uracil Analog U-359 on breast Cancer cell carcinogenesis","volume":"26","author":"D\u0142ugosz-Pokorska","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:11:32Z","timestamp":1770973892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"alternative-id":["S0045206826001057"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109569","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of novel procaspase-3 activators for the targeted therapy of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109569"}}